The mammalian retina displays no intrinsic regenerative capacities, therefore retinal
degenerative diseases such as age-related macular degeneration (AMD) or retinitis …

There is a rise in the number of people who have vision loss due to retinal diseases, and
conventional therapies for treating retinal degeneration fail to repair and regenerate the …

Photoreceptor replacement by transplantation is proposed as a treatment for blindness.
Transplantation of healthy photoreceptor precursor cells into diseased murine eyes leads to …

Cell transplantation is a potential strategy for treating blindness caused by the loss of
photoreceptors. Although transplanted rod-precursor cells are able to migrate into the adult …

Although label-free cell sorting is desirable for providing pristine cells for further analysis or
use, current approaches lack molecular specificity and speed. Here, we combine real-time …

Irreversible blindness caused by loss of photoreceptors may be amenable to cell therapy.
We previously demonstrated retinal repair and restoration of vision through transplantation …

Photoreceptor transplantation is a potential future treatment for blindness caused by retinal
degeneration. Photoreceptor transplantation restores visual responses in end-stage retinal …

Pre-clinical studies provided evidence for successful photoreceptor cell replacement
therapy. Migration and integration of donor photoreceptors into the retina has been …

One strategy to restore vision in retinitis pigmentosa and age-related macular degeneration
is cell replacement. Typically, patients lose vision when the outer retinal photoreceptor layer …

Retinal ganglion cell (RGC) death in glaucoma and other optic neuropathies results in
irreversible vision loss due to the mammalian central nervous system's limited regenerative …